Unity Biotechnology, Inc.
UBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8 | $20 | $13 | $33 |
| Short-Term Investments | $16 | $23 | $82 | $55 |
| Receivables | $0 | $2 | $0 | $0 |
| Inventory | $0 | $0 | -$0 | $0 |
| Other Curr. Assets | $1 | $2 | $2 | $2 |
| Total Curr. Assets | $24 | $47 | $97 | $91 |
| Property Plant & Equip (Net) | $12 | $18 | $27 | $31 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $1 | $1 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $1 |
| Total NC Assets | $13 | $19 | $28 | $34 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $38 | $66 | $124 | $125 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $2 | $2 |
| Short-Term Debt | $4 | $3 | $13 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $3 | $5 | $7 |
| Total Curr. Liab. | $9 | $8 | $20 | $17 |
| LT Debt | $20 | $24 | $38 | $49 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $6 | $11 | $0 |
| Total NC Liab. | $22 | $29 | $49 | $49 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $24 | $27 | $30 | $34 |
| Total Liabilities | $31 | $37 | $58 | $65 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$510 | -$484 | -$444 | -$400 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $517 | $513 | $501 | $460 |
| Total Equity | $6 | $28 | $56 | $60 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $38 | $66 | $124 | $125 |
| Net Debt | $16 | $7 | $38 | $23 |